Launches | PharmaShots

Mylan Launches Remdesivir Under the Brand Name Desrem for COVID-19 in India

July 21, 2020July 21, 2020Tuba Khan

Shots: Mylan launches Desrem (remdesivir) addressing the unmet needs amid COVID-19. The drug is approved for the treatment of suspected or laboratory-confirmed incidences [Read More...]

Novartis Launches Zero Profit Portfolio for Symptomatic Treatment of COVID-19

July 16, 2020July 16, 2020Tuba Khan

Shots: Novartis will offer a portfolio of 15 generic and OTC medicines addressing the need of low- and lower-middle-income countries to treat patients [Read More...]

Cipla Prices Ceprimi as Rs 4,000 per vial

Cipla Launches Cipremi at $53.34 per Vial in India

July 10, 2020July 10, 2020Tuba Khan

Shots: Cipla has priced its generic version of remdesivir, Cipremi at Rs 4000 ($53.34/ 100ml) vial, making it the lowest priced COVID-19 therapy [Read More...]

Sandoz Launches the Biosimilars Generation Campaign in Canada

June 26, 2020June 26, 2020Tuba Khan

Shots: The Biosimilar Generation Campaign provides needed, fact-based, information for patients and HCPs about biosimilar in Canada. The campaign seeks to increase awareness [Read More...]

Roche Launches uPath PD-L1 (SP263) Automated Digital Pathology Algorithm to Speed Up NSCLC Diagnosis

June 26, 2020June 26, 2020Tuba Khan

Shots: uPath PD-L1 (SP263) image analysis utilizes automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumor cell [Read More...]

The US FDA Launches Project Patient Voice to Share Patient-Reported Outcomes from Cancer Trials

June 24, 2020June 24, 2020Tuba Khan

Shots: The US FDA has launched the new pilot program to share patient-reported symptoms during clinical cancer drug trials. Project Patient Voice is [Read More...]

ATAI Launches IntroSpect Digital Therapeutics to Foster Mental Health Care

June 23, 2020June 23, 2020Tuba Khan

Shots: ATAI launches digital therapeutic platform IntroSpect Digital Therapeutics to transform mental health care and support companies working on new treatments for depression, [Read More...]

Cipla Launches Cipremi (remdesivir lyophilised powder for injection 100 mg) to Treat Patients with Severe COVID-19

Cipla Launches Cipremi (remdesivir lyophilized powder for injection 100 mg) to Treat Patients with Severe COVID-19

June 22, 2020June 22, 2020Tuba Khan

Shots: The US FDA has issued a EUA to Gilead for emergency use of remdesivir to treat hospitalized COVID-19 patients. In May, Gilead [Read More...]

Glenmark Launches FabiFlu (favipiravir) as the First Oral Medication to Treat Mild to Moderate COVID-19 in India

June 22, 2020June 22, 2020Tuba Khan

Shots: Glenmark has received manufacturing and marketing approval for its antiviral drug FabiFlu (favipiravir) to treat COVID-19 in India. The drug will be [Read More...]

Samsung Launches a Blood Pressure Monitoring App in South Korea

June 18, 2020June 18, 2020Tuba Khan

Shots: The launch of the Samsung Health Monitor application follows MFDS’ clearance in April. Galaxy Watch Active2 users can measure and track their [Read More...]